Jean-Sébastien Garrigue

Part of Santen Pharmaceutical Co., Ltd., Santen SAS is a French company that conducts drug discovery and clinical development on a global basis. The company is based in Evry, France. The company has a comprehensive portfolio across glaucoma and dry eye, and has also expanded into the surgical and vision correction arenas. Santen's long-term vision is to become a social innovator in ophthalmology and address social and economic issues related to eye health.

Novagali Pharma SA specializes in research, development and marketing of ophthalmic drugs. Their product pipeline includes products at various stages of development, which address diseases encountered at the three different segment levels of the eye which are surface, anterior and posterior segments. Some of these diseases are dry eye, allergy, glaucoma and retinopathies. Their formulations are based on their technology platforms Novasorb and Eyeject, which optimize bioavailability of drugs as well as safety and comfort for the patient. The company was founded on August 8, 2000 and is headquartered in Evry, France.